UPDATE
: 2019.12.10 ȭ 07:04
ó
α
ȸ
Medi Academy Archive
Clinical Selection
Medi Treat & Law
M Channel Archive
Medi
Pharmacy
Observation
Policy
Global
Opinion
Issue
ī
û
ü纸
ܿ
'MURANO 4 Ʈ м' , ٹƾø 'ŬŸø ' Ǵ 81% ̼ȯ(MRD)
'MURANO 4 Ʈ м' , ٹƾø 'ŬŸø ' Ǵ 81% ̼ȯ(MRD)
ٴ 'CKD-348''CKD-495'CKD-516' 3ǰ ӻ 3 Ρѱȭ 'PF-06651600'ѱν 'ƼƮ(RO554-1267)'ѱMSD 'MK-7339 Olaparib'ѱBMS 'Nivolumab' 3 ӻ
ٴ 'CKD-348''CKD-495'CKD-516' 3ǰ ӻ 3 Ρѱȭ 'PF-06651600'ѱν 'ƼƮ(RO554-1267)'ѱMSD 'MK-7339 Olaparib'ѱBMS 'Nivolumab' 3 ӻ
Takeda Presents 18-Month Data from Pivotal Phase 3 Trial of Dengue Vaccine Candidate at the American Society of Tropical Medicine and Hygiene(ASTMH) 68th Annual Meeting
Takeda Presents 18-Month Data from Pivotal Phase 3 Trial of Dengue Vaccine Candidate at the American Society of Tropical Medicine and Hygiene(ASTMH) 68th Annual Meeting
icon
渮 ̾ ڸ, ȣ ŷڡ ã '2019 -We Believe' ᡦ'We Believe ' 'ȸ ߡ' ȣ ŷڡ
icon
' Green Santa Coming Day ' ǥ "ʷϻŸ Ȱ õȯơȯ 'ǰ 'μ ֵ "
icon
'뺸 ũ ũ Ʈ ' ѱ 뺸 ũ Ʈ, ۰ ะ ο ִ ̵鿡 ' Ρ ϴ '
Clinical Selection
'MURANO 4 Ʈ м' , ٹƾø 'ŬŸø ' Ǵ 81% ̼ȯ(MRD)
'MURANO 4 Ʈ м' , ٹƾø 'ŬŸø ' Ǵ 81% ̼ȯ(MRD)
'GADOLIN ӻ ' 2 ̻ ġῡ '̹+ٹƾ' κδ 30%, ̹ ܵ() κδ 30%
'GADOLIN ӻ ' 2 ̻ ġῡ '̹+ٹƾ' κδ 30%, ̹ ܵ() κδ 30%
Ǵ 系 Ӽ 'BRCA ̸ ǥ ϴ ̼ ġ ֽ' ǥհǴ ΰ 躴 'Ҿ ġἭ ο ӻ ġ'
Ǵ 系 Ӽ 'BRCA ̸ ǥ ϴ ̼ ġ ֽ' ǥհǴ ΰ 躴 'Ҿ ġἭ ο ӻ ġ'
'The stories behind the headlines: A spotlight on obesity in Asia' '뺸 ũ ȭ ̵ '뺸 ũ, '2019 λ 索 ȸ' 'ȭ ̵ 硤 '
'The stories behind the headlines: A spotlight on obesity in Asia' '뺸 ũ ȭ ̵ '뺸 ũ, '2019 λ 索 ȸ' 'ȭ ̵ 硤 '
Medi Academy Archive
ϺǷȸ ' 츮 ' Ű 2 ̻ ü ' Ƿ غ' ߰мȸ
ϺǷȸ ' 츮 ' Ű 2 ̻ ü ' Ƿ غ' ߰мȸ
'Ǻΰȸ ȯ ǥ' Ǻΰȸ ȸ(߾Ӵ뺴 Ǻΰ ) , ġ ȸ ȯ ν ġ ȯ "
'Ǻΰȸ ȯ ǥ' Ǻΰȸ ȸ(߾Ӵ뺴 Ǻΰ ) , ġ ȸ ȯ ν ġ ȯ "
Ѽȭ⳻ðȸ, 'Ϲ ˾ƾ ϴ 峻ð ˻ ' ޡѼȭ⳻ðȸ ڼ (Ŵ뺹) " ȸ ΰǰ Ǵ پ ϰڴ"
Ѽȭ⳻ðȸ, 'Ϲ ˾ƾ ϴ 峻ð ˻ ' ޡѼȭ⳻ðȸ ڼ (Ŵ뺹) " ȸ ΰǰ Ǵ پ ϰڴ"
'ѱ Ƿ ° ' Ͽȸ ȸ塤系ȸ ̻塤ѱν ȣ ǥ̻ 'ѱ Ƿ ° '
'ѱ Ƿ ° ' Ͽȸ ȸ塤系ȸ ̻塤ѱν ȣ ǥ̻ 'ѱ Ƿ ° '
Medi Treat & Law
ٴ 'CKD-348''CKD-495'CKD-516' 3ǰ ӻ 3 Ρѱȭ 'PF-06651600'ѱν 'ƼƮ(RO554-1267)'ѱMSD 'MK-7339 Olaparib'ѱBMS 'Nivolumab' 3 ӻ
ٴ 'CKD-348''CKD-495'CKD-516' 3ǰ ӻ 3 Ρѱȭ 'PF-06651600'ѱν 'ƼƮ(RO554-1267)'ѱMSD 'MK-7339 Olaparib'ѱBMS 'Nivolumab' 3 ӻ
ȭǰ '˸Ʈ뿬ĸ10mg' 'ŸŸ0.5mg' 'ƮŸ' ż 'Ʈĸ80mg' 'ĭ8mg'ȭ 'Ʈ16' డ
ȭǰ '˸Ʈ뿬ĸ10mg' 'ŸŸ0.5mg' 'ƮŸ' ż 'Ʈĸ80mg' 'ĭ8mg'ȭ 'Ʈ16' డ
ѱἾ 'ܼŸ OROS ' Methylphenidate HCl 汸 ' ' áLGȭ 'Ʈ' Somatropin ֻ ' 153cm 165cm' Ȯ
ѱἾ 'ܼŸ OROS ' Methylphenidate HCl 汸 ' ' áLGȭ 'Ʈ' Somatropin ֻ ' 153cm 165cm' Ȯ
Ͼǰ ȸ Ͼ̿ 'Ʈ' 1 'GC7002 2.5mg' 1 Ρ 'Ϸνɿ5mg'ȱǰ 'ټ5mg' ǰ ڼ 1
Ͼǰ ȸ Ͼ̿ 'Ʈ' 1 'GC7002 2.5mg' 1 Ρ 'Ϸνɿ5mg'ȱǰ 'ټ5mg' ǰ ڼ 1
M Channel Archive
渮 ̾ ڸ, ȣ ŷڡ ã '2019 -We Believe' ᡦ'We Believe ' 'ȸ ߡ' ȣ ŷڡ
渮 ̾ ڸ, ȣ ŷڡ ã '2019 -We Believe' ᡦ'We Believe ' 'ȸ ߡ' ȣ ŷڡ
' Green Santa Coming Day ' ǥ "ʷϻŸ Ȱ õȯơȯ 'ǰ 'μ ֵ "
' Green Santa Coming Day ' ǥ "ʷϻŸ Ȱ õȯơȯ 'ǰ 'μ ֵ "
'뺸 ũ ũ Ʈ ' ѱ 뺸 ũ Ʈ, ۰ ะ ο ִ ̵鿡 ' Ρ ϴ '
'뺸 ũ ũ Ʈ ' ѱ 뺸 ũ Ʈ, ۰ ะ ο ִ ̵鿡 ' Ρ ϴ '
'ֺ ױ⡤ź Ȱ' ѱֺ ҿ ǥ̻ ѱֺ 2013 ų Բ ϴ 縦 õε õ ֵ "
'ֺ ױ⡤ź Ȱ' ѱֺ ҿ ǥ̻ ѱֺ 2013 ų Բ ϴ 縦 õε õ ֵ "
Observation
GC, 'ȸ' 2019 ȸ ֡ϼ GC ȸ ̾ ġ ִ ȸ ŵ쳯 ֵ ּ ͡
, 'ȸ' 8ȸ ۳ ֡ 130
ȸ , ' å̻' Ź"ϰ پ , ǻ硤Ƿ о˵ "
, 'ǰ濵ý ǥ ISO 9001 ȹ' Ȱ "ISO 9001 ȹ ' ۷ι ž ŷڵ' ̰ ƴ"
ѹ̾ǰ, ' CCR4 汸 鿪' ԡ'̱ Ʈκ ѱ߱(븸ȫ ) Ǹ' Ȯ
Medi View Archive
' ϴ ħ ' , ǰѾߡġϸ 'ſ ģ պ'
' ϴ ħ ' ,
뺴 缱а , '索 缱 ' Ǽ ġ (Cancer Management and Research) 11ȣ
뺴 缱а , '索
Ŭν+̵ ġ ȿ, SCI м 'ӻȸ' 硦뺴 峻 ȯ , 'IgA ġῡ ο ش'
Ŭν+̵ ġ ȿ, SCI
ARCHIVE
PREV
NEXT
, 'ƽþ ' 'ġ ž ǥ' ָ ۷ι ġ 'First-in-class ž'
' ϴ ħ ' , ǰѾߡġϸ 'ſ ģ պ'
渮 ̾ ڸ, ȣ ŷڡ ã '2019 -We Believe' ᡦ'We Believe ' 'ȸ ߡ' ȣ ŷڡ
'MURANO 4 Ʈ м' , ٹƾø 'ŬŸø ' Ǵ 81% ̼ȯ(MRD)
' Green Santa Coming Day ' ǥ "ʷϻŸ Ȱ õȯơȯ 'ǰ 'μ ֵ "
뺴 缱а , '索 缱 ' Ǽ ġ (Cancer Management and Research) 11ȣ
'뺸 ũ ũ Ʈ ' ѱ 뺸 ũ Ʈ, ۰ ะ ο ִ ̵鿡 ' Ρ ϴ '
GC, 'ȸ' 2019 ȸ ֡ϼ GC ȸ ̾ ġ ִ ȸ ŵ쳯 ֵ ּ ͡
, 'ȸ' 8ȸ ۳ ֡ 130
ȱǰ, 'ISO37001 ɻ ' 'й濵ý ' ISO37001(й濵ý) İɻ缭
Pharmacy Archive
ѱ " Ǿǰ 弭 ȭ"ѱ, '/ֻ硤丣ֻ硤õīĸ' Ǹ
ѱ " Ǿǰ 弭 ȭ"ѱ, '/ֻ硤丣ֻ硤õīĸ' Ǹ
ѱֽȸ(ǥ̻: ) 12 2Ϻη ѱƽڶ Ǹϴ /ֻ, ...
'ֺ AbbVie-Walk 2019 ' ѱֺ ҿ ǥ̻ ' ǥ ȸ Ī η ȯ ' ǹִ α 80% ̻ ִ"
'ֺ AbbVie-Walk 2019 ' ѱֺ ҿ ǥ̻ ' ǥ ȸ Ī η ȯ ' ǹִ α 80% ̻ ִ"
ѱֺ(ǥ̻ ҿ) 10 1Ϻ 11 30ϱ 2 ϡ͡ġȯ ȯ ...
渮 ̾ ڸ ̽¿ ǥ "渮, HIV ε ġ Բϸ ȯ µ ϰڴ"渮, '帮 ķ'
渮 ̾ ڸ ̽¿ ǥ "渮, HIV ε ġ Բϸ ȯ µ ϰڴ"渮, '帮 ķ'
渮 ̾ ڸ(ǥ̻ ̽¿) (12 1, World AIDS Day) ...
Opinion Archive
'ߡ߸ ' ȯ ٸ١߳ α 20% ߡ߸ ȣ
'ߡ߸ ' ȯ ٸ١߳ α 20% ߡ߸ ȣ
' ' vs '' ?Ȱ, 'ȯ ǰ ȸ ɷ ' ġ
' ' vs '' ?Ȱ, 'ȯ ǰ ȸ ɷ ' ġ
ܿö θ Ǽ, ؾ ұ?'ܿö Ǽ Ρó' Ǽ, Ǻο ַ 鿪ü ̻
ܿö θ Ǽ, ؾ ұ?'ܿö Ǽ Ρó' Ǽ, Ǻο ַ 鿪ü ̻
' ģ ܿ£ ()?' ܿö ' ټ Ǻ' ȯڿԴ 'ȣ'
' ģ ܿ£ ()?' ܿö ' ټ Ǻ' ȯڿԴ 'ȣ'
People Archive
Zﺴ , Ѽȭȸ ̻
ȭǰ, ̸ ԡȭǰ ڱȯ "23ȣ ž ں žళ 'ȭǰ R&D 絵' "
ȾϺ , 'ѸʽŰȸ 4 ȸ'
15 б ǹ Ƿ忡 迵
, 'ƽþ ' 'ġ ž ǥ' ָ ۷ι ġ 'First-in-class ž'
, 'ƽþ ' 'ġ ž ǥ' ָ ۷ι ġ 'First-in-class ž'
(ǥ ȣ) 7 õ ۵ о Žž мȸ '8ȸ ...
' ϴ ħ ' , ǰѾߡġϸ 'ſ ģ պ'
渮 ̾ ڸ, ȣ ŷڡ ã '2019 -We Believe' ᡦ'We Believe ' 'ȸ ߡ' ȣ ŷڡ
'MURANO 4 Ʈ м' , ٹƾø 'ŬŸø ' Ǵ 81% ̼ȯ(MRD)
' Green Santa Coming Day ' ǥ "ʷϻŸ Ȱ õȯơȯ 'ǰ 'μ ֵ "
뺴 缱а , '索 缱 ' Ǽ ġ (Cancer Management and Research) 11ȣ
'뺸 ũ ũ Ʈ ' ѱ 뺸 ũ Ʈ, ۰ ะ ο ִ ̵鿡 ' Ρ ϴ '
GC, 'ȸ' 2019 ȸ ֡ϼ GC ȸ ̾ ġ ִ ȸ ŵ쳯 ֵ ּ ͡
GC, 'ȸ' 2019 ȸ ֡ϼ GC ȸ ̾ ġ ִ ȸ ŵ쳯 ֵ ּ ͡
GC(ǥ ö) 6 ο ġ GC R&D Ϳ GC ...
, 'ȸ' 8ȸ ۳ ֡ 130
ȱǰ, 'ISO37001 ɻ ' 'й濵ý ' ISO37001(й濵ý) İɻ缭
ٴ 'CKD-348''CKD-495'CKD-516' 3ǰ ӻ 3 Ρѱȭ 'PF-06651600'ѱν 'ƼƮ(RO554-1267)'ѱMSD 'MK-7339 Olaparib'ѱBMS 'Nivolumab' 3 ӻ
Zﺴ , Ѽȭȸ ̻
ȸ , ' å̻' Ź"ϰ پ , ǻ硤Ƿ о˵ "
, 'ǰ濵ý ǥ ISO 9001 ȹ' Ȱ "ISO 9001 ȹ ' ۷ι ž ŷڵ' ̰ ƴ"
˻
Clinical Selection
'MURANO 4 Ʈ м' , ٹƾø 'ŬŸø ' Ǵ 81% ̼ȯ(MRD)
'GADOLIN ӻ ' 2 ̻ ġῡ '̹+ٹƾ' κδ 30%, ̹ ܵ() κδ 30%
Ǵ 系 Ӽ 'BRCA ̸ ǥ ϴ ̼ ġ ֽ' ǥհǴ ΰ 躴 'Ҿ ġἭ ο ӻ ġ'
'The stories behind the headlines: A spotlight on obesity in Asia' '뺸 ũ ȭ ̵ '뺸 ũ, '2019 λ 索 ȸ' 'ȭ ̵ 硤 '
뺴 к ȣ (Ѱȸ ̻) ' ٰ Ȳֽ ġ߰ ̺Ƽ ӻ Ұ' ǥڸ, ۿ ٰ ġ '̺Ƽ'
ֺ ī̸ġ, 'ߵ ǻ Ǽ ͷŲ-23 ' 㰡'2ȸ ġ 16 10 7.5 Ǻ PASI 90 ' 1 Ŀ Ǻ ȿ
' 1ȸ TOUCH the ESMO ' ù (ƻ꺴 系) 塦 "Ÿ CARD ӻ '̼ ȯ ' ġ "
Medi Academy Archive
ϺǷȸ ' 츮 ' Ű 2 ̻ ü ' Ƿ غ' ߰мȸ
'Ǻΰȸ ȯ ǥ' Ǻΰȸ ȸ(߾Ӵ뺴 Ǻΰ ) , ġ ȸ ȯ ν ġ ȯ "
Ѽȭ⳻ðȸ, 'Ϲ ˾ƾ ϴ 峻ð ˻ ' ޡѼȭ⳻ðȸ ڼ (Ŵ뺹) " ȸ ΰǰ Ǵ پ ϰڴ"
'ѱ Ƿ ° ' Ͽȸ ȸ塤系ȸ ̻塤ѱν ȣ ǥ̻ 'ѱ Ƿ ° '
'系ȸ 2019 ķ' 系ȸ ̻(뺴) " ġ ƴ ֱ ž ݾ ġ ȿ ִ"
'系ȸ ȸ' ̻(뺴) λ縻 ѹ̻(뺴) ' ô 系 ǻ Ұ ǥд缭뺴 ȾϺ ڰȭ ǥ
Ǻΰȸ ȸ , Ǻ Ϻο Ÿ ܿ ٸ ȯ ġ ʿ伺 ġñ ġ "' ٷξ˱ Ʈ'
M Channel Archive
渮 ̾ ڸ, ȣ ŷڡ ã '2019 -We Believe' ᡦ'We Believe ' 'ȸ ߡ' ȣ ŷڡ
' Green Santa Coming Day ' ǥ "ʷϻŸ Ȱ õȯơȯ 'ǰ 'μ ֵ "
'뺸 ũ ũ Ʈ ' ѱ 뺸 ũ Ʈ, ۰ ะ ο ִ ̵鿡 ' Ρ ϴ '
'ֺ ױ⡤ź Ȱ' ѱֺ ҿ ǥ̻ ѱֺ 2013 ų Բ ϴ 縦 õε õ ֵ "
ѱƽƮī ǥ ǥ̻ ѱƽƮī, ȸ Ȱ 'ȯ ߽ ö' "ѱƽƮī, Ρȸȸ ְ 'ȸ '
1
2
3
4
5
Medi Treat & Law
ٴ 'CKD-348''CKD-495'CKD-516' 3ǰ ӻ 3 Ρѱȭ 'PF-06651600'ѱν 'ƼƮ(RO554-1267)'ѱMSD 'MK-7339 Olaparib'ѱBMS 'Nivolumab' 3 ӻ
ȭǰ '˸Ʈ뿬ĸ10mg' 'ŸŸ0.5mg' 'ƮŸ' ż 'Ʈĸ80mg' 'ĭ8mg'ȭ 'Ʈ16' డ
ѱἾ 'ܼŸ OROS ' Methylphenidate HCl 汸 ' ' áLGȭ 'Ʈ' Somatropin ֻ ' 153cm 165cm' Ȯ
Ͼǰ ȸ Ͼ̿ 'Ʈ' 1 'GC7002 2.5mg' 1 Ρ 'Ϸνɿ5mg'ȱǰ 'ټ5mg' ǰ ڼ 1
ѵ 'ĶƮ' Deflazacort 汸, Ⱓ ġ ʿ 'Ҿ ' ѱΰ 'Ƽֻ' Alteplase ֻ,
1
2
3
4
5
Archive
1
Takeda Presents 18-Month Data from Pivotal Phase 3 Trial of Dengue Vaccine Candidate at the American Society of Tropical Medicine and Hygiene(ASTMH) 68th Annual Meeting
2
뺴 к ȣ (Ѱȸ ̻) ' ٰ Ȳֽ ġ߰ ̺Ƽ ӻ Ұ' ǥڸ, ۿ ٰ ġ '̺Ƽ'
3
Ǵ 系 Ӽ 'BRCA ̸ ǥ ϴ ̼ ġ ֽ' ǥհǴ ΰ 躴 'Ҿ ġἭ ο ӻ ġ'
4
ֺ ī̸ġ, 'ߵ ǻ Ǽ ͷŲ-23 ' 㰡'2ȸ ġ 16 10 7.5 Ǻ PASI 90 ' 1 Ŀ Ǻ ȿ
5
ȭǰ '˸Ʈ뿬ĸ10mg' 'ŸŸ0.5mg' 'ƮŸ' ż 'Ʈĸ80mg' 'ĭ8mg'ȭ 'Ʈ16' డ
6
'GADOLIN ӻ ' 2 ̻ ġῡ '̹+ٹƾ' κδ 30%, ̹ ܵ() κδ 30%
7
ѱƽƮī ǥ ǥ̻ ѱƽƮī, ȸ Ȱ 'ȯ ߽ ö' "ѱƽƮī, Ρȸȸ ְ 'ȸ '
Issue
, 'ƽþ ' 'ġ ž ǥ' ָ ۷ι ġ 'First-in-class ž'
ȱǰ, 'ISO37001 ɻ ' 'й濵ý ' ISO37001(й濵ý) İɻ缭
ѹ̾ǰ, 'ѱȸ ߰мȸ м' ' (Ǵ 峻) (Ǵ ȯ⳻) ' (Ǵ 峻) (Ǵ ȯ⳻) ǥ
'ѡASEAN ' Ȯ롦ٴ硤ƿƼ '÷ Ǿǰ 塤žళ ȸ'
ѹ̾ǰ, 'Ѱȸ ߰мȸ м' áǴ Ǵ ǥ
Policy
' Ȳ 㰡 ʱ' ɷ ȭ 롦'23 PRADA Ű Ǿǰ ' 'Ǿǰ : '
'뺴 Կ㱳 Ȯ' " ' ' ȯ "Կȯ,
JWСͽ, 'Ϸǰ' '̿ȸ û' Ȱȭ
' R&D ں' ѹ̾ǰ 18.7%ٴ 12.6%ƿƼ 11.6%GC 11%'ǰ ü װ ǥ' ̿ R&D ' ̳'
ѡ ȸ, 'Ǿǰ ' '6ȸ ѡ ̳ ߱ ȸ ǥ ' Ǹ 濵 å
Observation
GC, 'ȸ' 2019 ȸ ֡ϼ GC ȸ ̾ ġ ִ ȸ ŵ쳯 ֵ ּ ͡
, 'ȸ' 8ȸ ۳ ֡ 130
ȸ , ' å̻' Ź"ϰ پ , ǻ硤Ƿ о˵ "
, 'ǰ濵ý ǥ ISO 9001 ȹ' Ȱ "ISO 9001 ȹ ' ۷ι ž ŷڵ' ̰ ƴ"
ѹ̾ǰ, ' CCR4 汸 鿪' ԡ'̱ Ʈκ ѱ߱(븸ȫ ) Ǹ' Ȯ
Treat Leader Archive
ѹ̾ǰ ȸ ѹ̻̾ ǥ ̿÷ ǡ " ̳뺣̼, K-̿ Ż "
'EGFR 3 ǥġ Ƽ ȿ' ö , ' ž ӻ ݷ' ù
'Better Health, Brighter Future' ѱɴ ǥ "ɴ ' ȯ ġ ϴ ' "ѱɴ 1 ̾ ù ຸ
迬 뺴 ִ û?迬 뺴 "뺴, '츮 Ƿ 'μ 3 Ѿ 4 Ƿ ؾ"
"žళ ֻ '' ǰ 'žళ ̿コ Ⱓȭ' ؾ"
뺴 ȿ , 'ɱٱ⼼ ǥ ' Ը ' ְ Circulation ''ջ ϴ ġ' ȭ
ѱ̿ȸ ȸ 츮 Ǿǰ EU ȭƮƮ ϴ 'ǰ '' ؿ ' Ȱ ϰڴ" ̿ȸ ' ' ȭ
Global
Takeda Presents 18-Month Data from Pivotal Phase 3 Trial of Dengue Vaccine Candidate at the American Society of Tropical Medicine and Hygiene(ASTMH) 68th Annual Meeting
Takeda Announces 12 New Molecular Entities with the Potential for 14 Launches in the Next Five Years at 2019 R&D Day
Interim analysis from EMPRISE real-world study shows empagliflozin decreased risk of hospitalisation for heart failure compared with DPP-4 inhibitors and GLP-1 receptor agonists
GSK, ̿ ̹³ĸ ' ġ ' ޡGSK ġ '̿ ' ȭ
ι ڻ "Ƿ Ư 1 ġἭ ' ȯ ġ ɼ ' ſ ߿"Լ '̼ 1 ġμ Ϲ̵ ʱ 1/2 ' ǥ
Back to Top